Effect of off-label use of oncology drugs on pharmaceutical costs: The rituximab experience

被引：0
|
作者：
Kocs, D
Fendrick, AM
机构：
[1] Univ Michigan, Med Ctr, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Publ Hlth, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, CHOICES, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF MANAGED CARE | 2003年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
GOAL To provide comprehensive and current information concerning the. off-label use of oncology drugs and its effects on pharmaceutical costs. AUDIENCE This activity is designed for pharmacy & therapeutics committee members; group practice directors; physicians specializing in oncology; hospital administrators; and institutional, home-health and/or infusion pharmacists. LEARNING OBJECTIVES Upon completion of this educational activity, the participant should be able to: Interpret the definition and meaning of "off-label" use of a drug. List the pertinent factors that promote, inhibit, or have a mixed influence on off-label use of a drug. Discuss the influence on oncology drug expenditures of off-label use of oncology drugs, with specific emphasis on rituximab costs.
引用
收藏
页码：393 / 400
页数：8
相关论文
共 50 条
  • [31] Extent and patterns of off-label use of rituximab for SLE
    Sanz, Inaki
    Nature Reviews Rheumatology, 2016, 12 (12) : 700 - U23
  • [32] OFF-LABEL USE OF BEVACIZUMAB IN ONCOLOGY PATIENTS. INFLUENCE ON EFFECTIVENESS, SECURITY AND COSTS
    Marin Pozo, Juan Francisco
    Duarte Perez, Juan Manuel
    Sanchez Rovira, Pedro
    FARMACIA, 2017, 65 (06) : 843 - 850
  • [33] Use of off-label anti tumour drugs
    Viano, Ilario
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2007, 8 : 15 - 18
  • [34] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
  • [35] The peculiarities of off-label use of drugs in pediatrics
    Drohovoz, S. M.
    Butko, Ya O.
    Ivantsyk, L. B.
    Shchokina, C. H.
    Bielik, H., V
    Lukianchuk, V. D.
    ZAPOROZHYE MEDICAL JOURNAL, 2020, 22 (05) : 714 - 718
  • [36] Tackling Off-Label Use of Anticancer Drugs
    Perrone, Francesco
    de Braud, Filippo
    Labianca, Roberto
    Tomino, Carlo
    Roila, Fausto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) : 2800 - 2800
  • [37] Off-label use of drugs in psychiatry and neurology
    Wallesch, CW
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2004, 72 (05) : 243 - 244
  • [38] Off-label use of drugs - the legal framework
    Koyuncu, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (30) : 1519 - 1523
  • [39] Off-label use of drugs: An evil or a necessity?
    Gota, Vikram
    Divatia, Jigeeshu V.
    INDIAN JOURNAL OF ANAESTHESIA, 2015, 59 (12) : 767 - 768
  • [40] Chinese Regulation of Off-label Use of Drugs
    Ma, Feng
    Lou, Nan
    FOOD AND DRUG LAW JOURNAL, 2013, 68 (02) : 189 - 200
12345